Article

Pupil dilator gets FDA approval

The FDA has authorized Akorn Inc. to market Paramyd, a topical mydriatic/cycloplegic combination product in eye drop form.The drops work quickly to provide short-lasting pupil dilation.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
© 2025 MJH Life Sciences

All rights reserved.